Genelux Corp (NASDAQ:GNLX) price on Friday, June 13, rose 15.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.06.
A look at the stock’s price movement, the close in the last trading session was $2.65. Turning to its 52-week performance, $5.89 and $1.60 were the 52-week high and 52-week low respectively. Overall, GNLX moved 27.50% over the past month.
Genelux Corp’s market cap currently stands at around $115.47 million, with investors looking forward to this quarter’s earnings report slated for in July.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend GNLX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GNLX’s current price about 18.67% and 18.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 64.52, while 7-day volatility ratio is 7.59% and 4.93% in the 30-day chart. Further, Genelux Corp (GNLX) has a beta value of -0.51, and an average true range (ATR) of 0.25.
If we refocus on Genelux Corp (NASDAQ:GNLX), historical trading data shows that trading volumes averaged 165.32K over the past 3 months. The company’s latest data on shares outstanding shows there are 37.73 million shares.
The 13.15% of Genelux Corp’s shares are in the hands of company insiders while institutional holders own 19.55% of the company’s shares. Current price change has pushed the stock 29.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GNLX stock continues to rise going into the next quarter.
